Immunocompromised Host
COVID-19 unlikely to ‘fade away’ for the immunocompromised: ‘It’s good to have options’
COVID-19 fears and complications are likely to persist far into the future for immunocompromised individuals, a speaker noted at the Basic and Clinical Immunology for the Busy Clinician symposium.
A Shot in the Dark: 'Limited data' exist for COVID-19 booster in immunocompromised patients
Immunocompromised individuals have a number of justifiable concerns surrounding COVID-19. One of those concerns is that a two-dose vaccine schedule may not produce a sufficient antibody response to protect them from the virus.
Older, immunosuppressed patients at higher risk for flu vaccine failure, complications
A study found that older and immunosuppressed patients are at an increased risk for influenza vaccine failure and influenza complications, researchers reported.
Flu vaccine effectiveness low among immunocompromised patients
Influenza vaccine effectiveness was significantly lower among immunocompromised adults compared with nonimmunocompromised adults during the severe 2017-2018 influenza season, according to a study.
Next-generation sequencing assay demonstrates high sensitivity
A commercially available next-generation sequencing, or NGS, plasma assay demonstrated high sensitivity in both immunocompromised and non-immunocompromised children with one or more bacterial, viral or fungal infection compared with conventional diagnostic testing in a single-center study published in Open Forum Infectious Diseases.